Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 193

Sort by

Sort Order Select

Journal Articles

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Santiago Arroyo, MD PhD, Renger G Tiessen, MD, William S Denney, PhD, Jim Jin, MS, Mattheus Paulus (Thijs) van Iersel, MD, Heidi Zeitz, MD CCRA, Anthony M Manning, PhD, Martin R. Schipperus, MD PhD, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1090.

https://doi.org/10.1182/blood-2019-125993

Published: 2019

Journal Articles

Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 4 Years Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B

Wolfgang Miesbach, MD PhD, Karina Meijer, Michiel Coppens, MD, Peter Kampmann, MD, Dr. Klamroth, Roger Schutgens, MD PhD MSc, Giancarlo Castaman, MD, Erhard Seifried, MD PhD, Joachim Schwaeble, Halvard Bönig, Eileen K Sawyer, PhD, Frank W.G. Leebeek, MD PhD

Blood (2019) 134 (Supplement_1): 2059.

https://doi.org/10.1182/blood-2019-122535

Published: 2019

Journal Articles

Secondary Autoimmune Neutropenia: Data from the Italian Neutropenia Registry

Francesca Fioredda, PhD, Piero Farruggia, Andrea Beccaria, Antonino Trizzino, LuciaDora Notarangelo, Tiziana Lanza, Andrea Rotulo, Isabella Ceccherini, Angela Guarina, Alice Grossi, Federico Verzegnassi, Elena Mastrodicasa, Laura Luti, Angelica Barone, Giovanna Russo, Laura Porretti, Marta Pillon, Maurizio Miano, Carlo Dufour

Blood (2019) 134 (Supplement_1): 3585.

https://doi.org/10.1182/blood-2019-126526

Published: 2019

Journal Articles

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Blood (2019) 134 (Supplement_1): 570.

https://doi.org/10.1182/blood-2019-128178

Published: 2019

Journal Articles

Challenges in Management of Severe Hemophilia with Acute Hematologic Malignancies

Akshat Jain, MDMPH, Mary Meyer

Blood (2019) 134 (Supplement_1): 4940.

https://doi.org/10.1182/blood-2019-124895

Published: 2019

Journal Articles

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Mohammed Abdullah Alsheef, MD, Kamal Gazal, MD, Nahar Alenizi, MD, Khalid Qushmaq, MD, Mukhtar Alomar, PharmD, Ghaydaa Juma Kullab, MD, Abdul Rehman Z. Zaidi, MBBS

Blood (2019) 134 (Supplement_1): 4955.

https://doi.org/10.1182/blood-2019-130548

Published: 2019

Journal Articles

Low-Grade Inflammation in Hemophilia

Lynn M Knowles, PhD, Hermann Eichler, Jan Pilch, MD

Blood (2019) 134 (Supplement_1): 1115.

https://doi.org/10.1182/blood-2019-125127

Published: 2019

Journal Articles

A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP)

Geoff O Gillard, Jennifer L Proctor, BS, Melissa L. Brooks, BS, Tahirih L Lamothe, BS, Sharon L. Hyzy, MS, Oliver Mikse, Sean McDonough, Rahul Palchaudhuri, PhD, Anjali Bhat, MS, Ganapathy N. Sarma, PhD, Prashant Bhattarai, Pranoti Sawant, MS, Bradley R Pearse, PhD, Charlotte F. Mcdonough, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD

Blood (2019) 134 (Supplement_1): 3208.

https://doi.org/10.1182/blood-2019-130752

Published: 2019

Journal Articles

Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia

Andrew B Song, BA, David J. Kuter, Hanny Al-Samkari, MD

Blood (2019) 134 (Supplement_1): 959.

https://doi.org/10.1182/blood-2019-122359

Published: 2019

Journal Articles

The Mutation Profile of Myelodysplastic Syndrome Associated with Auto-Immune Rheumatological Disorders

Lih En Hong, MBBS, Deepak Singhal, MBBS, MD FRACP, FRCPA, Amilia Wee, BSc (Hons), Rakchha Chhetri, MBBS, Mihir D Wechalekar, MBBS, MD FRACP, PhD, Susanna Proudman, MBBS, MD FRACP, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2018) 132 (Supplement 1): 3081.

https://doi.org/10.1182/blood-2018-99-119965

Published: 2018

Journal Articles

Rheumatoid Arthritis Causes Hematopoietic Stem Cell Reprogramming to Maintain Functionality

Blood (2018) 132 (Supplement 1): 2573.

https://doi.org/10.1182/blood-2018-99-120272

Published: 2018

Journal Articles

Macrophage Polarization Is Impaired in Hemophilia

Lynn M Knowles, PhD, Daniela Lessig, Martin Bernard, Eva C Schwarz, PhD, Hermann Eichler, MD, Jan Pilch, MD

Blood (2018) 132 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2018-99-117111

Published: 2018

Journal Articles

Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML

Ibraheem H. Motabi, MD, Shahid Iqbal, MD, Syed Ziauddin A. Zaidi, FRCP, FRCPath, MBBS, Belal Albtoosh, BSc, RN, Nawal Faiez Alshehry, MD, Mubarak S. AlGhamdi, MD, Imran Khan Tailor, MD, Syed Altaf, MD

Blood (2018) 132 (Supplement 1): 5181.

https://doi.org/10.1182/blood-2018-99-114037

Published: 2018

Journal Articles

Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients with Del(5q) — Preliminary Blinded Analysis of the European Sintra-REV Trial

Blood (2018) 132 (Supplement 1): 468.

https://doi.org/10.1182/blood-2018-99-119430

Published: 2018

Journal Articles

Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 1435.

https://doi.org/10.1182/blood-2018-99-118764

Published: 2018

Journal Articles

The Efficacy of Ultrasound Joint Examination for the Management in Patients with Hemophilia

Shiho Nishimura, MD, Keita Tomioka, MD, Maiko Shimomura, MD, Yoko Mizoguchi, MD PhD, Shinobu Sasaki, Chihiro Tani, MD PhD, Yoshiko Matsubara, Kazuo Awai, MD PhD, Yuko Nakashima, MD PhD, Nobuo Adachi, MD PhD, Masao Kobayashi, MD PhD

Blood (2018) 132 (Supplement 1): 5027.

https://doi.org/10.1182/blood-2018-99-120016

Published: 2018

Journal Articles

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

Verena Petzer, MD, Piotr Tymoszuk, PhD, Matthew Wake, PhD, Luke Bayliss, BSc, Jonathan Papworth, BSc, Joana Carvalho, PhD, Cecilia Deantonio, PhD, Malte Ferdinand Asshoff, MD, Markus Seifert, Sylvia Berger, Dominik Wolf, MD, Günter Weiss, MD, Volker Germaschewski, PhD, Igor Theurl, MD PhD

Blood (2018) 132 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2018-99-115747

Published: 2018

Journal Articles

A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412: Arms G-I)

Catherine Diefenbach, MD, Fangxin Hong, PhD, Richard F Ambinder, MD, Jonathon B. Cohen, MDMS, Michael Robertson, MD, Kevin A. David, MD, Ranjana H. Advani, MD, Timothy S. Fenske, MD, Stefan Klaus Barta, MDMRCP,MS, Neil Palmisano, MD, Jakub Svoboda, MD, David Morgan, MD, Reem Karmali, MD, Brad S Kahl, MD, Stephen M. Ansell, MD PhD

Blood (2018) 132 (Supplement 1): 679.

https://doi.org/10.1182/blood-2018-99-115390

Published: 2018

Journal Articles

Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease

Kam Sandhu, Kaledas Flintoff, Mark D. Chatfield, Jeannette L. Dixon, Louise E. Ramm, Grant A. Ramm, Lawrie W. Powell, V. Nathan Subramaniam, Daniel F. Wallace

Blood (2018) 132 (1): 101–110.

https://doi.org/10.1182/blood-2018-02-830562

Published: 2018

Includes: Supplemental data

Journal Articles

Quantitative Sensory Testing in Children with Sickle Cell Disease

Robin E Miller, MD, Dawn S Brown, PCNS,FNP,CCRC, Sarah E Hegarty, MPhil, Scott W Keith, PhD, Benjamin E Leiby, PhD, Yamaja Setty, PhD, Suhita Gayen-Betal, PhD, Claudia M Campbell, PhD, Marie Stuart, MD

Blood (2017) 130 (Supplement 1): 3541.

https://doi.org/10.1182/blood.V130.Suppl_1.3541.3541

Published: 2017

NARROW

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 4 Years Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B

Secondary Autoimmune Neutropenia: Data from the Italian Neutropenia Registry

Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Challenges in Management of Severe Hemophilia with Acute Hematologic Malignancies

Vasculo-Behcet's Disease: Profile and Management - Single Center Experience

Low-Grade Inflammation in Hemophilia

A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP)

Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia

The Mutation Profile of Myelodysplastic Syndrome Associated with Auto-Immune Rheumatological Disorders

Rheumatoid Arthritis Causes Hematopoietic Stem Cell Reprogramming to Maintain Functionality

Macrophage Polarization Is Impaired in Hemophilia

Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML

Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients with Del(5q) — Preliminary Blinded Analysis of the European Sintra-REV Trial

Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia

The Efficacy of Ultrasound Joint Examination for the Management in Patients with Hemophilia

A Fully Human Anti-BMP6 Antibody Reduces the Need for Erythropoietin Stimulating Agent in Two Rodent Anemia of Chronic Disease Models

A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412: Arms G-I)

Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease

Quantitative Sensory Testing in Children with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only